BRAIN CANCER

HER2 Breast Cancer

BREAST CANCER

Bladder Cancer

Prostate Cancer

Renal Cell Carcinoma

GENITOURINARY CANCERS

Liquid Biopsies

GENOMIC TESTING

Colorectal Cancer

GIST

Gastric Cancer

GI CANCERS

Cervical Cancer

Endometrial Cancer

Ovarian Cancer

GYNECOLOGIC CANCERS

HEAD & NECK CANCERS

Bone Marrow & Stem Cell Transplant

HEMATOLOGY

CAR T-Cell Therapy

IMMUNOTHERAPY

Chronic Lymphocytic Leukemia

Chronic Myeloid Leukemia

LEUKEMIAS

Biomarker-Driven Lung Cancer

EGFR+ Lung Cancer

MET-Targeted Therapy

Small Cell Lung Cancer

LUNG CANCER

DLBCL

Follicular Lymphoma

Mantle Cell Lymphoma

LYMPHOMAS

MPNs

MULTIPLE MYELOMA

NTRK GENE FUSIONS

SARCOMA

Melanoma

SKIN CANCERS

THYROID CANCERS

NEWS

All News

FDA Briefs

Oncology Icons

Special Reports

The Targeted Pulse

Voices from the Field

CONFERENCES

Conference Coverage

Conference Listing

Data Dialogue with the Oncology Brothers

MEDIA

All Videos

Case-Based Peer Perspectives

Expert Perspective Virtual Tumor Board

Interviews

Investigator Perspectives

Medical World News

Pivotal Practice Views with the Oncology Brothers

Podcasts

Precision Medicine

Speaking Out

PUBLICATIONS

All Publications

Evolving Paradigms

Peers & Perspectives in Oncology

Targeted Therapies in Oncology

CASE-BASED ROUNDTABLE

PARTNERS

RESOURCES

CME/CE

Clinical Trials

Precision Medicine Perspectives

Press Releases

Treatment Resources

SUBSCRIBE

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy for oncologists treating patients in a community setting.

About Us

Advertise

Contact Us

CureToday.com

CancerNetwork.com

OncLive.com

OncNursingNews.com

Do Not Sell My Information

Privacy

Terms & Conditions

Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

Facebook

Linkedin

YouTube

Instagram

Featured Clinical Focus

BTK Inhibitors: In-Focus

Bone Marrow & SCT

EGFR-Positive Lung Cancer

Lung Cancer

Multiple Myeloma

Thyroid Cancers

Clinical Focus

Brain Cancer

Breast Cancer

Gastrointestinal Cancer

Genitourinary Cancers

Gynecologic Cancers

Head & Neck Cancers

Hematology

Leukemias

Lymphomas

Sarcoma

Skin Cancers

Spotlight

Targeted Oncology's Data Dialogue with the Oncology Brothers is a video series that covers major medical conferences with discussions about abstract data from key clinical trials.

1rem

With Stephen Liu, MD, the Oncology Brothers review 4 major studies highlighted at the European Society for Medical Oncology (ESMO) Congress 2024, including the LAURA study, the MARIPOSA and MARIPOSA-2 studies, and the ADRIATIC study.

Lung Cancer ESMO 2024 Highlights

Rahul Gosain, MD; Rohit Gosain, MD; and Kristen Ciombor, MD, discuss recent clinical trial results from ESMO 2024, including LEAP-012 in lung cancer, KEYNOTE-811 in gastric cancer, POD1UM-303/InterAACT2 in anal cancer, and NICHE-2 in colorectal cancer, highlighting advancements in immunotherapy and targeted treatments across multiple tumor types.

GI Cancer ESMO 2024 Highlights

Rahul Gosain, MD; Rohit Gosain, MD, and Petros Grivas, MD, examine recent oncology studies presented at ESMO 2024, including TiNivo-2, PEACE-3, and CONTACT-02, focusing on survival outcomes, combination therapies, and treatment efficacy in specific patient populations with metastatic disease.

GU Cancer ESMO 2024 Highlights

Rahul Gosain, MD; Rohit Gosain, MD, and Paolo Tarantino, MD, analyze recent oncology trial results presented at ESMO 2024, focusing on primary endpoints, survival outcomes, and progression-free survival data across multiple studies including NATALEE, KEYNOTE-522, and DESTINYBreast-12.

Breast Cancer ESMO 2024 Highlights

Experts at World Conference on Lung Cancer 2024 analyze critical lung cancer studies including HARMONi-02, SKIPPirr, and TROPION-Lung01, examining end points such as progression-free survival, overall survival across histologies, and the potential of novel treatments like amivantamab to advance therapeutic strategies for various patient subgroups.

World Conference on Lung Cancer 2024

Following the 2024 ASCO Annual Meeting, Mark A. Lewis, MD, joins the Oncology Brothers, Rohit Gosain, MD, and Rahul Gosain, MD, to discuss recent updates in gastrointestinal cancer.

GI Cancer ASCO 2024 Highlights

Following the 2024 ASCO Annual Meeting, Toni Choueiri, MD, joins the Oncology Brothers, Rahul Gosain, MD, and Rohit Gosain, MD, to discuss recent updates in genitourinary cancer.

GU Cancer ASCO 2024 Highlights

Following the 2024 ASCO Annual Meeting, Erika P. Hamilton, MD, joins the Oncology Brothers, Rahul Gosain, MD, and Rohit Gosain, MD, to review recent updates in breast cancer.

Breast Cancer ASCO 2024 Highlights

Joshua K. Sabari, MD, joins the Oncology Brothers, Rahul Gosain, MD, and Rohit Gosain, MD, to discuss recent updates and exciting data presented at the 2024 ASCO Annual Meeting.

Lung Cancer ASCO 2024 Highlights

Following ASCO GU 2024, Tian Zhang, MD, joins the Oncology Brothers, Rahul Gosain, MD, and Rohit Gosain, MD, to review recent data in patients with genitourinary cancers.

Highlights from ASCO GU 2024

Following GI ASCO 2024, Pamela Kunz, MD, joins the Oncology Brothers, Rohit Gosain, MD, and Rahul Gosain, MD, to discuss key clinical trial data updates in colorectal cancer, hepatocellular carcinoma, neuroendocrine tumor, and the role of ctDNA.

GI ASCO 2024 Highlights

Following ASH 2023, Uma Borate, MBBS, joins the Oncology Brothers, Rohit Gosain, MD, and Rahul Gosain, MD, to discuss key clinical trial data updates in myelofibrosis and acute myeloid leukemia.

Key Data Updates in MF and AML from ASH 2023

Following SABCS 2023, Daniel Stover, MD, joins the Oncology Brothers, Rohit Gosain, MD, and Rahul Gosain, MD, to discuss key clinical trial data updates in HER2+ Breast Cancer.

Key Data Updates in HER2+ Breast Cancer from SABCS 2023

Following the 2023 San Antonio Breast Cancer Symposium, Hope Rugo, MD joins the Oncology Brothers, Rohit Gosain, MD, and Rahul Gosain, MD, to discuss key clinical trial data updates in HR+, HER2- Breast Cancer.

Key Data Updates in HR+/HER2- Breast Cancer from SABCS 2023

Following ASH 2023, Mazyar Shadman, MD, MPH, joins the Oncology Brothers, Rahul Gosain, MD, and Rohit Gosain, MD, to discuss key data updates in leukemia and lymphoma presented at the 2023 ASH Annual Meeting.

Key Data Updates in Leukemia and Lymphoma from ASH 2023

Following ASH 2023, Jens Hillengass, MD, PhD, joins the Oncology Brothers, Rahul Gosain, MD, and Rohit Gosain, MD, to discuss key data updates in multiple myeloma presented at the 2023 ASH Annual Meeting.

Key Data Updates in Multiple Myeloma from ASH 2023

Following SABCS 2023, Eleonora Teplinsky, MD, joins the Oncology Brothers, Rohit Gosain, MD, and Rahul Gosain, MD, to discuss key clinical trial data updates in breast cancer.

Key Data Updates in Breast Cancer from SABCS 2023

The Oncology Brothers, Rohit Gosain, MD, and Rahul Gosain, MD, are joined by Rachna Shroff, MD, to discuss recent data updates in gastrointestinal cancers from clinical trials presented at the 2023 ESMO Congress Meeting.

GI Cancer ESMO 2023 Highlights

Join the Oncology Brothers as they work with expert Alexander Spira, MD, PhD, FACP, in reviewing key updates from ESMO 2023 centered on the management of lung cancer.

Lung Cancer ESMO 2023 Highlights 

Following ESMO 2023, Erika P. Hamilton, MD, joins the Oncology Brothers, Rohit Gosain, MD, and Rahul Gosain, MD, to discuss recent clinical trial data in breast cancer.

Breast Cancer ESMO 2023 Highlights

The Oncology Brothers Rahul Gosain, MD, and Rohit Gosain, MD are joined by Rana McKay, MD, to review data from three key clinical trials in GU cancer following updates at ESMO 2023.

GU Cancer ESMO 2023 Highlights 

The oncology Brothers Rohit Gosain, MD, and Rahul Gosain, MD, are joined by expert Stephen Liu, MD, to review key data from the IALSC 2023 World Conference on Lung Cancer and consider their impact on clinical practice.

Key Data Updates From IASLC 2023 World Conference on Lung Cancer  

The Oncology Brothers, Rohit Gosain, MD, and Rahul Gosain, MD, are joined by Muhammad Shaalan Beg, MD, to discuss recent data updates in gastrointestinal cancers from clinical trials presented at the 2023 ASCO Annual Meeting.

GI Cancer ASCO 2023 Highlights

The Oncology Brothers, Rohit Gosain, MD, and Rahul Gosain, MD, are joined by Toni Choueiri, MD, following the 2023 ASCO Annual Meeting to discuss recent data updates in the genitourinary cancer space.

Recent Data in Genitourinary Cancers at ASCO 2023

The Oncology Brothers, Rohit Gosain, MD, and Rahul Gosain, MD, are joined by Charu Aggarwal, MD, MPH, to discuss recent lung cancer data updates from clinical trials presented at the 2023 ASCO Annual Meeting.

Data Updates in Lung Cancer at ASCO 2023

The Oncology Brothers, joined by key opinion leader Stephanie Graff, MD, FACP, review clinical data from three key studies in breast cancer management and consider how they will impact the broader treatment landscape.

Breast Cancer ASCO 2023 Highlights  